Crop Life Science reports FY26 net profit of ₹698.69 lakh
Crop Life Science Limited reported a net profit of ₹698.69 lakh for FY26, up from ₹662.03 lakh in the previous year, with revenue rising to ₹20,717.42 lakh. The Board approved the audited financial results on May 26, 2026, receiving an unmodified opinion from statutory auditors. Consolidated net profit increased to ₹649.49 lakh, while total assets grew to ₹20,531.69 lakh.

*this image is generated using AI for illustrative purposes only.
Crop Life Science Limited reported a net profit of ₹698.69 lakh for the financial year ended March 31, 2026, an increase from ₹662.03 lakh in the previous year. Revenue from operations rose to ₹20,717.42 lakh for FY26, compared to ₹20,059.00 lakh in FY25. The company’s basic and diluted earnings per share stood at ₹4.08 for the year, up from ₹3.86 in the prior year.
The Board of Directors approved the audited standalone and consolidated financial statements for the half year and year ended March 31, 2026, at its meeting held on May 26, 2026. Shah & Shah, Chartered Accountants, issued an audit report with an unmodified opinion on the financial results. The statutory auditors confirmed that the results give a true and fair view in conformity with the Indian Accounting Standards.
Standalone Financial Performance
For the year ended March 31, 2026, total income stood at ₹20,888.52 lakh, a slight increase from ₹20,157.16 lakh in the previous year. Total expenses for the period were ₹19,904.37 lakh, compared to ₹19,256.08 lakh in FY25. The profit before exceptional items was ₹984.15 lakh, while exceptional items for the year amounted to ₹6.28 lakh.
| Particulars | Year Ended March 31, 2026 (₹ in Lacs) | Year Ended March 31, 2025 (₹ in Lacs) |
|---|---|---|
| Revenue from operations | 20,717.42 | 20,059.00 |
| Total income | 20,888.52 | 20,157.16 |
| Total expenses | 19,904.37 | 19,256.08 |
| Net profit for the year | 698.69 | 662.03 |
| Basic EPS (₹) | 4.08 | 3.86 |
Consolidated Financial Results
On a consolidated basis, the company reported a net profit of ₹649.49 lakh for FY26, up from ₹560.11 lakh in the previous year. Total consolidated revenue from operations was ₹20,717.42 lakh, matching the standalone figures. Profit attributable to the owners of the company stood at ₹663.51 lakh, while non-controlling interest was recorded at a loss of ₹14.02 lakh.
| Particulars | Year Ended March 31, 2026 (₹ in Lacs) | Year Ended March 31, 2025 (₹ in Lacs) |
|---|---|---|
| Revenue from operations | 20,717.42 | 20,059.00 |
| Total income | 20,894.42 | 20,160.73 |
| Total expenses | 19,977.48 | 19,381.15 |
| Net profit for the year | 649.49 | 560.11 |
| Basic EPS (₹) | 3.79 | 3.27 |
Financial Position and Cash Flows
The total assets of the company stood at ₹20,531.69 lakh as of March 31, 2026, up from ₹17,770.69 lakh in the previous year. Total equity increased to ₹8,534.52 lakh from ₹7,820.18 lakh. The net cash flow from operating activities was negative at ₹(791.45) lakh, primarily due to changes in working capital. The company reported a net increase in cash and cash equivalents of ₹1,555.31 lakh during the year.
Historical Stock Returns for Crop Life Science
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | +6.51% | -3.81% | -15.00% | -10.71% | -16.84% |
What strategies will the company implement to reverse the negative operating cash flow driven by working capital changes?
How does Crop Life Science plan to utilize the significant increase in total assets to drive future revenue growth?
Will the company maintain its current expense management strategy to sustain profit margins amidst rising operational costs?


























